COMMUNIQUÉS West-GlobeNewswire

MPX Completes Acquisition of Canadian Licensed Producer
11/06/2018
TORONTO, June 11, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that it has successfully completed the acquisition of 100% of the issued [...]
Summit Unveils Second Novel Target for Gonorrhoea at ASM Microbe 2018
11/06/2018
Highlights the Power of the Discuva Platform to Identify Novel Antibiotic Targets OXFORD, United Kingdom and CAMBRIDGE, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) announces [...]
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Year-end Financial Results on June 15, 2018
11/06/2018
Financials for Fiscal Year 2018 Ended March 31, 2018 will be released on June 14, 2018 NORTHVALE, N.J., June 11, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty [...]
Global campaign during 10th annual National Blood Donor Week highlights need for blood
11/06/2018
44,000 blood donors needed across the country by Canada Day OTTAWA, June 11, 2018 (GLOBE NEWSWIRE) -- Canadian Blood Services is getting ready to support patients this summer and is inviting Canadians to participate in [...]
Une campagne internationale et la dixième Semaine nationale du don de sang attirent l’attention sur les besoins en sang
11/06/2018
Nous avons besoin de 44 000 donneurs d’ici la fête du Canada OTTAWA, 11 juin 2018 (GLOBE NEWSWIRE) -- Pour pouvoir répondre aux besoins des patients cet été, la Société canadienne du sang invite la population à [...]
International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical Trial
11/06/2018
CARLSBAD, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
MediWound Completes Enrollment in NexoBrid® U.S. Phase 3 DETECT Study
11/06/2018
Top-line acute data currently expected around year end 2018 YAVNE, Israel, June 11, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to [...]
Neuralstem Awarded Phase I SBIR Contract to Support Research into Neural Stem Cell Therapy for Severe Traumatic Brain Injury
11/06/2018
GERMANTOWN, Md., June 11, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that it has been awarded a Phase I [...]
Transactions under Novozymes’ stock buyback program
11/06/2018
Please read the full announcement in the attached PDF Attachment 2018_38_Stock_Buybackprogram_EN
Novo Nordisk A/S - Share repurchase programme
11/06/2018
Bagsværd, Denmark, 11 June 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
Tetraphase Pharmaceuticals Announces Data from a Pooled Analysis of IGNITE1 and IGNITE4 Phase 3 Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections at the ASM Microbe 2018 Annual Meeting
11/06/2018
Eravacycline Global Surveillance and TP-6076 Data Also Highlighted WATERTOWN, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing [...]
Dynavax to Present at the William Blair 38th Annual Growth Stock Conference
11/06/2018
BERKELEY, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that Michael Ostrach, Dynavax’s Chief Financial Officer, will present at the William Blair 38th Annual [...]
Vical Reports Phase 2 Trial of HSV-2 Therapeutic Vaccine Did Not Meet Primary Endpoint
11/06/2018
Company to focus on advancing VL-2397 and other pipeline opportunities SAN DIEGO, June 11, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced top-line results from a randomized, double-blind, [...]
Fennec Pharmaceuticals Set to Join Russell 3000 Index
11/06/2018
RESEARCH TRIANGLE PARK, N.C., June 11, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX), a specialty pharmaceutical company focused on the development of PEDMARK TM (a unique formulation of [...]
Solon Eiendom ASA : Primary insider notification
11/06/2018
(Oslo, Norway, 11 June 2018) Reference is made to Solon Eiendom ASA's (the "Company") prospectus dated 16 May 2018 (the "Prospectus") for inter alia the subsequent offering (the "Subsequent Offering") of up to 396,040 [...]
Solon Eiendom ASA : Final result of the subsequent offering
11/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Summit Therapeutics Unveils Second Novel Target for Gonorrhoea at ASM Microbe 2018
11/06/2018
Summit Therapeutics plc ("Summit" or the "Company") Summit Unveils Second Novel Target for Gonorrhoea at ASM Microbe 2018 Highlights the Power of the Discuva Platform to Identify Novel Antibiotic Targets Oxford, UK, and [...]
Shire plc : Rule 2.9 Announcement
11/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 11 June 2018 Shire [...]
Saniona plans Phase 2a study for treatment of Hypothalamic Obesity
11/06/2018
PRESS RELEASE June 11, 2018 Saniona, a leading biotech company within ion-channel research, today announced that it plans to initiate a clinical Phase 2a study in the rare eating disorder hypothalamic obesity with its [...]

Pages